| 43 |
Kim, T. H., and Lee, S.-W. (2022) Therapeutic application of genome editing technologies in viral diseases. International Journal of Molecular Sciences 23(10): 45399. |
|
| 42 |
Kim, T. H., and Lee, S.-W. (2021) Aptamers for anti-viral therapeutics and diagnostics. International Journal of Molecular Sciences 22(8): 4168. |
|
| 41 |
Han, S. R., Lee, C. H., Im, J. Y., Kim, J. H., Kim, J. H., Kim, S. J., Cho, Y. W., Kim, E., Kim, Y., Ryu, J.-H., Ju, M. H., Jeong, J. S., and Lee, S.-W. (2021) Targeted suicide gene therapy for liver cancer based on ribozyme-mediated RNA replacement throu |
|
| 40 |
Seo, M.-J., Park, J. H., Lee, K. C., Lee, Y. J., Lee, T. S., Choi, T. H., Lee, S.-W., Kim, K. I., and Kang, J. H. (2020) Small animal PET imaging of hTERT RNA-targeted HSV1-tk gene expression with trans-splicing ribozyme. Cancer Biotherapy and Radiopharma |
|
| 39 |
Lee, C. H., Han, S. R., and Lee, S.-W. (2018) Group I intron-based therapeutics through trans-splicing reaction. Progress in Molecular Biology and Translational Science 159: 79-100. |
|
| 38 |
Lee, C. H., Han, S. R., and Lee, S.-W. (2018) Therapeutic applications of group I intron-based trans-splicing ribozymes. WIREs RNA 9(3): e1466. |
|
| 37 |
Kim, S. J., Kim, J. H., Yang, B., Jeong, J.-S., and Lee, S.-W. (2017) Specific and efficient regression of cancers harboring KRAS mutation by targeted RNA replacement. Molecular Therapy 25(2): 356-367. |
|
| 36 |
Kim, Y.-H., Kim, K. T., Lee, S.-J., Hong, S.-H., Moon, J. Y., Yoon, E. K., Kim, S., Kim, E. O., Kang, S. H., Kim, S. K., Choi, S. I., Goh, S. H., Kim, D., Lee, S.-W., Ju, M. H., Jeong, J. S., and Kim, I.-H. (2016) Image-guided suicide gene therapy utilizi |
|
| 35 |
Won, Y. S., Jeong, J.-S., Kim, S. J., Ju, M. H., and Lee, S.-W. (2015) Targeted anticancer effect through microRNA-181a regulated tumor-specific hTERT replacement. Cancer Letters 356(2): 918-928. |
|
| 34 |
Kim, J., Won, R., Ban, G., Ju, M. H., Cho, K. S., Han, S. Y., Jeong, J.-S., and Lee, S.-W. (2015) Targeted regression of hepatocellular carcinoma by cancer-specific RNA replacement through microRNA regulation. Scientific Reports 5, 12315. |
|
